ANI PHARMACEUTICALS, INC Number of Reportable Segments
ANI PHARMACEUTICALS, INC (ANIP) reported Number of Reportable Segments of 2 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC number of reportable segments for fiscal 2012 was 1.00 item.
item
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2012-12-31 | 1.00 item 10-K · filed 2013-02-28 |
| 2011-12-31 | 1.00 item 8-K · filed 2013-01-28 |
segment
| Period end | Number of Reportable Segments | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 2.00 segment 10-Q · filed 2026-08-07 | ||||
| 2026-03-31 | 2.00 segment 10-Q · filed 2026-05-08 | ||||
| 2025-12-31 | 2.00 segment 10-K · filed 2026-02-27 | ||||
| 2023-12-31 | 2.00 segment 10-K · filed 2024-02-29 | ||||
| 2023-06-30 | 2.00 segment 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | 2.00 segment 10-Q · filed 2023-05-08 | ||||
| 2022-12-31 | 2.00 segment 10-K · filed 2023-03-09 | ||||
| 2022-09-30 | 2.00 segment 10-Q · filed 2022-11-09 | ||||
| 2022-06-30 | 2.00 segment 10-Q · filed 2022-08-08 | ||||
| 2022-03-31 | 2.00 segment 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | 1.00 segment 10-K · filed 2024-02-29 | 1.00 segment 10-K · filed 2023-03-09 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-11-01 | ||||
| 2021-06-30 | 1.00 segment 10-Q · filed 2021-08-06 | ||||
| 2021-03-31 | 1.00 segment 10-Q · filed 2021-05-07 | ||||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-03-11 | ||||
| 2020-09-30 | 1.00 segment 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | 1.00 segment 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |